Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-02-13 | Elliot Favus, age 39, is Chief Executive Officer of Favus Institutional Research, a healthcare research firm... He attended the University of Michigan (BA, 1996), the University of Chicago Pritzker School of Medicine (MD, 2001)... He is board-certified in Internal Medicine and has 10 years of basic science laboratory experience. |
| 2016-04-01 | Elliot Favus, age 41, is Chief Executive Officer of Favus Institutional Research, a healthcare research firm... He attended the University of Michigan (BA, 1996), the University of Chicago Pritzker School of Medicine (MD, 2001)... He is board-certified in Internal Medicine and has 10 years of basic science laboratory experience working on human genetics projects. |
| 2017-03-10 | Elliot Favus, age 42, is Chief Executive Officer of Favus Institutional Research, a healthcare research firm. He attended the University of Michigan (BA), the University of Chicago Pritzker School of Medicine (MD), and has 10 years of basic science laboratory experience working on human genetics projects. |
| 2018-03-08 | Elliot Favus, age 43, is Chief Executive Officer of Favus Institutional Research, a healthcare research firm. He attended medical school and has 10 years of basic science laboratory experience working on human genetics projects. |
| 2019-02-11 | Elliot Favus, age 44, is Chief Executive Officer of Favus Institutional Research, a healthcare research firm serving institutional investors. ... He attended the University of Michigan (BA, 1996), the University of Chicago Pritzker School of Medicine (MD, 2001) and the NYU-Bellevue Hospital Internal Medicine Residency Program (2004). He is board-certified in Internal Medicine (2004) and has 10 years of basic science laboratory experience working on human genetics projects at Harvard Medical School, the University of Chicago and the University of Pittsburgh. |
| 2020-02-20 | Elliot Favus, age 45, is Chief Executive Officer of Favus Institutional Research, a healthcare research firm. He has been a healthcare equity research analyst on Wall Street since 2006 and has 10 years of basic science laboratory experience working on human genetics projects. |
Data sourced from SEC filings. Last updated: 2026-03-05